Reagent generation for bioanalytical method development for biologics
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95018D00010
- Awardee
-
A&G Pharmaceutical, Inc. UEI SN6SWFABJXL1
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 7 $440,071 obligated
Award facts
- Opportunity
-
- N01TR182006 Solicitation number
- Reagent Generation for Bioanalytical Method Development for Biologics Award Notice · Posted Oct 13, 2017
- Combined order value
-
- $440,071 Current, with exercised options
- $462,652 Potential, with all options
- Last date to order 93% complete
- IDV ceiling 63% used
- $696,028.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Basic Research
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a single-award Indefinite Delivery Contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, a for-profit manufacturer of goods. The contract, valued at a potential $696,028, aims to procure custom antibody development services in support of the agency's biomedical research initiatives. Through associated firm fixed price delivery orders, Precision Antibody will provide products such as monoclonal cell lines, monoclonal antibodies, labeled monoclonal antibodies, polyclonal antibodies, and drug-specific monoclonal antibodies against engineered proteins. These services will support research efforts in areas including Alzheimer's disease, malaria, COVID-19, oncology, and drug development at NIH component locations in Maryland. Precision Antibody has extensive experience providing similar antibody development services to HHS, including the National Cancer Institute and National Institute on Aging, through prior contract awards. The contract does not include any set-aside designations.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | -$5,000 | |
| Original award | $5,000 |
Quick answers
Who was awarded contract 75N95018D00010?
75N95018D00010 was awarded to A&G Pharmaceutical, Inc. by National Institute on Drug Abuse (National Institutes of Health) on June 6, 2018.
How much is contract 75N95018D00010 worth?
Orders under 75N95018D00010 have obligated $440,071. Their combined potential value, with all options, is $462,652. 75N95018D00010's own ceiling is $696,028.
How many orders have been placed under contract 75N95018D00010?
7 orders have been placed under 75N95018D00010, the latest on March 18, 2024.
Which agency awarded contract 75N95018D00010?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95018D00010, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Who can order from contract 75N95018D00010?
75N95018D00010 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95018D00010 competed?
The extent of competition for 75N95018D00010 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV